The Food and Drug Administration oversees a broad range of medical and consumer products. In fact, the agency estimates that the items it regulates account for 20 cents of each dollar Americans spend.
The health care products project worked to advance policies that would effectively protect consumers from dangerous products and reduce safety risks associated with new innovations in the marketplace. Its efforts focused on diagnostic tests, dietary supplements, over-the-counter drugs, and regenerative medicine. The project concluded in 2022.
Report October 22, 2021
Lab-Developed Tests in the In Vitro Diagnostics Market
Issue Brief August 5, 2021
How FDA Regulates Artificial Intelligence in Medical Products
Issue Brief June 1, 2021
Harms Linked to Unapproved Stem Cell Interventions
Fact Sheet December 18, 2019